LAB FY 2011 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena

LABStandard BioTools Inc.

$374M

FY 2011 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$43M+27.7% YoY

Gross Profit

$30M69.2% margin

Operating Income

-$19M-43.3% margin

Net Income

-$22M-52.4% margin

EPS (Diluted)

$-1.26

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$19M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$79M

Total Liabilities

$22M

Stockholders' Equity

$57M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$43M	$34M	+27.7%
Gross Profit	$30M	$22M	+35.0%
Operating Income	-$19M	-$15M	-27.4%
Net Income	-$22M	-$17M	-32.9%